Evaluation of Humoral Immune Response after SARS-CoV-2 Vaccination Using Two Binding Antibody Assays and a Neutralizing Antibody Assay

Multiple vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed and administered to mitigate the coronavirus disease 2019 (COVID-19) pandemic. We assessed the humoral response of BNT162b2 and ChAdOx1 nCoV-19 using Siemens SARS-CoV-2 IgG (sCOVG; cutoff of ≥1...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Minjeong, Seo, Jong Do, Moon, Hee-Won, Kim, Hanah, Hur, Mina, Yun, Yeo-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612149/
https://www.ncbi.nlm.nih.gov/pubmed/34817223
http://dx.doi.org/10.1128/Spectrum.01202-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612149/
https://www.ncbi.nlm.nih.gov/pubmed/34817223
http://dx.doi.org/10.1128/Spectrum.01202-21

Ejemplares similares